Patents by Inventor Daniel Abraham Muruve

Daniel Abraham Muruve has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240108686
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Application
    Filed: June 5, 2023
    Publication date: April 4, 2024
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Jennifer Joy Rahn, Arthur Wing SZE Lau, Daniel Abraham Muruve, Saurav Roy Choudhury, Liane Babes, Paul Kubes
  • Patent number: 11666631
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: June 6, 2023
    Assignee: Arch Biopartners, Inc.
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Jennifer Joy Rahn, Arthur Wing Sze Lau, Daniel Abraham Muruve, Saurav Roy Choudhury, Liane Babes, Paul Kubes
  • Publication number: 20220251140
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Application
    Filed: February 14, 2022
    Publication date: August 11, 2022
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Daniel Abraham Muruve, Saurav Roy Choudhury, Jennifer Joy Rahn, Arthur Wing Sze Lau, Justin MacDonald, Liane Babes, Paul Kubes
  • Patent number: 11286278
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: March 29, 2022
    Assignee: Arch BioPartners, Inc.
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Daniel Abraham Muruve, Saurav Roy Choudhury, Jennifer Joy Rahn, Arthur Wing Sze Lau, Justin MacDonald, Liane Babes, Paul Kubes
  • Publication number: 20200223888
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Application
    Filed: December 2, 2019
    Publication date: July 16, 2020
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Daniel Abraham Muruve, Saurav Roy Choudhury, Jennifer Joy Rahn, Arthur Wing Sze Lau, Justin MacDonald, Liane Babes, Paul Kubes
  • Publication number: 20200078442
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Application
    Filed: July 8, 2019
    Publication date: March 12, 2020
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Jennifer Joy Rahn, Arthur Wing SZE Lau, Daniel Abraham Muruve, Saurav Roy Choudhury, Liane Babes, Paul Kubes
  • Patent number: 10493127
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: December 3, 2019
    Assignee: Arch Biopartners, Inc.
    Inventors: Stephen Mark Robbins, Donna Lorraine Senger, Jennifer Joy Rahn, Arthur Wing Sze Lau, Daniel Abraham Muruve, Saurav Roy Choudhury, Liane Babes, Paul Kubes
  • Publication number: 20170258872
    Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
    Type: Application
    Filed: August 11, 2016
    Publication date: September 14, 2017
    Inventors: STEPHEN MARK ROBBINS, DONNA LORRAINE SENGER, JENNIFER JOY RAHN, ARTHUR WING SZE LAU, DANIEL ABRAHAM MURUVE, SAURAV ROY CHOUDHURY
  • Patent number: 9422450
    Abstract: The present invention relates to a methods and composition in which a D-form or retro-inverso Pseudomonas pilin peptide, optionally having a polyethylene glycol moiety covalently attached to the peptide, is bound to a substrate. The disclosed methods and composition are useful for reducing the frictional coefficient, inhibiting biofilm formation by non-Pseudomonas bacteria, for reducing the inflammatory response to a material, for reducing corrosion of metals, and in biosensor applications.
    Type: Grant
    Filed: April 13, 2012
    Date of Patent: August 23, 2016
    Assignee: ARCH BIOPHYSICS, INC.
    Inventors: Randall Thomas Irvin, Elisabeth Melika Davis, Dongyang Li, Daniel Abraham Muruve
  • Patent number: 9096775
    Abstract: The present invention relates to a methods and composition in which a D-form or retro-inverso Pseudomonas pilin peptide is bound to a substrate. The disclosed methods and composition are useful for inhibiting biofilm formation by non-Pseudomonas bacteria, for reducing the inflammatory response to a material, for reducing corrosion of metals, and in biosensor applications.
    Type: Grant
    Filed: April 14, 2011
    Date of Patent: August 4, 2015
    Assignee: Arch Biophysics, Inc.
    Inventors: Randall T. Irvin, Elisabeth M. Davis, DongYang Li, Daniel Abraham Muruve
  • Publication number: 20140220368
    Abstract: The present invention relates to a methods and composition in which a D-form or retro-inverso Pseudomonas pilin peptide, optionally having a polyethylene glycol moiety covalently attached to the peptide, is bound to a substrate. The disclosed methods and composition are useful for reducing the frictional coefficient, inhibiting biofilm formation by non-Pseudomonas bacteria, for reducing the inflammatory response to a material, for reducing corrosion of metals, and in biosensor applications.
    Type: Application
    Filed: April 13, 2012
    Publication date: August 7, 2014
    Applicant: ARCH BIOPHYSICS, INC.
    Inventors: Randall Thomas Irvin, Elisabeth Melika Davis, Gongyang Li, Daniel Abraham Muruve
  • Publication number: 20110293684
    Abstract: The present invention relates to a methods and composition in which a D-form or retro-inverso Pseudomonas pilin peptide is bound to a substrate. The disclosed methods and composition are useful for inhibiting biofilm formation by non-Pseudomonas bacteria, for reducing the inflammatory response to a material, for reducing corrosion of metals, and in biosensor applications.
    Type: Application
    Filed: April 14, 2011
    Publication date: December 1, 2011
    Applicant: ARCH BIOPHYSICS, INC.
    Inventors: Randall T. Irvin, Elisabeth M. Davis, DongYang Li, Daniel Abraham Muruve